Reference

AMET works diligently to keep the following information updated with the most current medical aesthetic news.  This information has been supplied by numerous sources. AMET is not affiliated with any such sources, and the information provided does not reflect the views of AMET.  The function of this page is to simply provide information, and AMET does not accept responsibility or liability for any views/claims/rumors/errors that appears herein.  

10/3/2010
Cosmetic surgery market predicted to double by 2017
The market for cosmetic surgery, facial aesthetics and lasers is expected to almost double in size and to exceed $3 billion over the next seven years.
Cosmetic surgery market predicted to double by 2017

The market for cosmetic surgery, facial aesthetics and lasers is expected to almost double in size and to exceed $3 billion over the next seven years, according to iData Research, a pharmaceutical market research firm based in Vancouver, British Columbia, PRNewswire reports.

The iData report estimates that the market for aesthetic botulinum toxin A drugs such as Botox (onabotulinumtoxinA, Allergan) will grow to an estimated $543 million by 2017, and that the aesthetic laser and light therapy markets for skin resurfacing, hair removal and laser lipolysis are the fastest-growing segments.

The U.S. market for aesthetic facial injectable products is valued at nearly $860 million now, according to the report. It adds that use of botulinum toxin is likely to increase due to the expected introduction of PurTox (Mentor), and also to a growing number of therapeutic possibilities.

PRNewswire quotes iData CEO Kamran Zamanian, Ph.D., as saying, A growing number of doctors are looking at the therapeutic potential of botulinum A. There are more cosmetic procedures performed using botulinum A than therapeutic; however, therapeutic procedures use higher doses of the drug, therefore these two markets are similar in value.

http://www.modernmedicine.com/modernmedicine/artic...

back to reference main